Breast Cancer and Quality of Life

NCT ID: NCT01661816

Last Updated: 2012-08-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

171 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-04-30

Study Completion Date

2008-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to analyse and decode interviews of patient with breast cancer, and then established according a multidimensional profile specific to the population and to create a questionnaire tha will allow a practical and qualitative evaluation of the quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

breast cancer everyday issues couple

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Within chemotherapy

30 couples, interviewed within chemotherapy (6 to 8 months after diagnosis)

interview

Intervention Type BEHAVIORAL

psychological, emotional, family and social parameters

within Herceptin

30 couples, within herceptin treatment (the first year after diagnosis)

interview

Intervention Type BEHAVIORAL

psychological, emotional, family and social parameters

within hormonotherapy

30 couples, within hormonotherapy (between 2 and 7 years after diagnosis)

interview

Intervention Type BEHAVIORAL

psychological, emotional, family and social parameters

without hormonotherapy

30 couples, did not received hormonotherapy (1 year after diagnosis)

interview

Intervention Type BEHAVIORAL

psychological, emotional, family and social parameters

end of treatment

30 couples, after end of treatments for patients who did received hormonotherapy (7 years after diagnosis)

interview

Intervention Type BEHAVIORAL

psychological, emotional, family and social parameters

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

interview

psychological, emotional, family and social parameters

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age \< 45
* non metastatic breast cancer
* at least 6 months of relationship

Exclusion Criteria

* no life partner
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Oscar Lambret

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

François Baclesse Center

Caen, , France

Site Status

Oscar Lambret Center

Lille, , France

Site Status

Gustave Roussy Institut

Paris, , France

Site Status

Hospital

Valenciennes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KALICOU

Identifier Type: -

Identifier Source: org_study_id